Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn s and Colitis Organisation (ECCO) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Entyvio maintenance therapy – given as a self-injection at home – led to Crohn's disease remission after one year in a Phase 3 study, Takeda Pharma said.
Remsima, an approved biosimilar of Remicade for active Crohn’s and ulcerative colitis, was safe and effective given as a potential under-the-skin injection.